L-Theanine
NootropicsFDA ApprovedAlso known as: gamma-glutamylethylamide, N-ethyl-L-glutamine, γ-L-glutamylethylamide, Suntheanine, Theanine
L-Theanine is a non-proteinogenic amino acid found almost exclusively in tea (Camellia sinensis) and a handful of edible mushrooms, and it has become the single most widely-used calm-focus nootropic in the modern supplement market — both on its own at 100-400mg doses and, even more prominently, as the classic 1:1 or 2:1 pair with caffeine that defines the "calm-focus" experiential signature of green tea and of virtually every serious nootropic stack. Chemically L-theanine is γ-glutamylethylamide (N-ethyl-L-glutamine), a structural analog of the excitatory neurotransmitter glutamate and its inhibitory cousin GABA — close enough to both to interact with their transporters and, at high doses, their receptors, but distinct enough to produce a characteristic combination of reduced sympathetic arousal, mildly enhanced alpha-wave EEG activity, and preserved or modestly improved attention that the literature has consistently tied to its single signature phrase: "relaxed alertness." The modern L-theanine literature traces back to Japanese tea-chemistry research in the 1950s — theanine was first isolated from green tea by Sakato in 1949 — but its Western nootropic adoption is much more recent, anchored by three key human studies: **Kobayashi et al.
Overview
At A Glance
L-Theanine is a weak, broad-spectrum neurotransmitter modulator that produces its "relaxed alertness" signature through small simultaneous effects on glutamate, GABA, monoamines, and cortical oscillatory activity — rather than through strong action at any single receptor. This mu…
Mechanism of Action
L-Theanine is a weak, broad-spectrum neurotransmitter modulator that produces its "relaxed alertness" signature through small simultaneous effects on glutamate, GABA, monoamines, and cortical oscillatory activity — rather than through strong action at any single receptor. This multi-target, low-potency pharmacology is the reason its subjective effects are so consistent across users yet so subtle in magnitude.
Glutamate-system modulation. L-theanine is structurally an N-ethyl analog of L-glutamine — close enough to glutamate-system molecules to be a weak competitive antagonist at ionotropic glutamate receptors (NMDA, AMPA, kainate) and a substrate/competitive inhibitor at the glutamate transporter (EAAT). At physiologic supplement doses (plasma L-theanine ~10-40 μM), these effects are weak — far below what is seen with selective NMDA antagonists like ketamine or memantine — but measurable and in the right direction to reduce excitatory tone in cortex and limbic structures. Importantly, L-theanine does NOT cause the dissociative or psychotomimetic effects of stronger NMDA antagonists. The practical role of glutamate modulation in L-theanine's clinical effect is probably small — the more important effects are monoaminergic and cortical-oscillatory.
GABA-system interaction. L-theanine is NOT a direct GABA-A or GABA-B agonist at any clinically relevant potency, contrary to a common oversimplification in marketing copy. Theanine does appear to modestly raise brain GABA concentrations in rodent studies (Yokogoshi 1998), likely through effects on GABA synthesis or release rather than direct receptor binding, but the magnitude is small — not comparable to benzodiazepines, barbiturates, or phenibut. This is why L-theanine does not produce sedation, disinhibition, anterograde amnesia, respiratory depression, or benzodiazepine-like tolerance and withdrawal.
Monoaminergic effects (probably most important clinically). The most consistently reported effect in controlled human studies is modest dampening of sympathetic nervous system activity — reduced heart rate, reduced blood pressure, reduced cortisol response to acute stress. Mechanistically this appears to involve central α2-adrenergic modulation and reduced noradrenergic output from the locus coeruleus. This is likely the substrate of the subjective "taking the edge off" effect that users describe with caffeine co-administration: caffeine raises sympathetic tone (heart rate, BP, cortisol reactivity); theanine partially offsets this without blunting the attention-improving adenosine-antagonist effects. L-theanine also modestly modulates dopaminergic and serotonergic transmission — small effects on dopamine and 5-HT release and receptor function have been described — which may contribute to mild mood elevation in some users.
Alpha-wave EEG induction. The best-characterised and most distinctive neurophysiological effect of L-theanine is dose-dependent enhancement of cortical alpha-wave activity (8-13 Hz) on EEG. This was first described by Kobayashi 1998 in Japanese subjects given 50-200mg oral doses and subsequently replicated in multiple studies (reviewed in Nobre 2008, PMID: 18296328). Alpha activity is associated with a state of "relaxed wakefulness" — alert enough for goal-directed behaviour, relaxed enough to not experience stress — and is the EEG signature of meditative and focused-but-not-stressed states. The magnitude of alpha-wave elevation from 200mg L-theanine is comparable to light meditation but smaller than that from experienced meditators or from benzodiazepines. This is the single most cited mechanistic signature of L-theanine and is the neurophysiological correlate of the subjective "calm focus" effect.
What theanine is NOT. Not a classical anxiolytic (no GABA-A agonism). Not a sedative (low-dose stimulants are needed to produce sleep enhancement). Not a stimulant (does not block adenosine, does not release catecholamines). Not a selective NMDA antagonist (far too weak). Not a monoamine reuptake inhibitor (no SSRI-like mechanism). Its modest, multi-target pharmacology places it in a distinct category from prescription psychotropics and is both the reason its clinical effects are subtle and the reason its safety profile is remarkably clean.
Overview
L-Theanine is a non-proteinogenic amino acid found almost exclusively in tea (Camellia sinensis) and a handful of edible mushrooms, and it has become the single most widely-used calm-focus nootropic in the modern supplement market — both on its own at 100-400mg doses and, even more prominently, as the classic 1:1 or 2:1 pair with caffeine that defines the "calm-focus" experiential signature of green tea and of virtually every serious nootropic stack. Chemically L-theanine is γ-glutamylethylamide (N-ethyl-L-glutamine), a structural analog of the excitatory neurotransmitter glutamate and its inhibitory cousin GABA — close enough to both to interact with their transporters and, at high doses, their receptors, but distinct enough to produce a characteristic combination of reduced sympathetic arousal, mildly enhanced alpha-wave EEG activity, and preserved or modestly improved attention that the literature has consistently tied to its single signature phrase: "relaxed alertness."
The modern L-theanine literature traces back to Japanese tea-chemistry research in the 1950s — theanine was first isolated from green tea by Sakato in 1949 — but its Western nootropic adoption is much more recent, anchored by three key human studies: Kobayashi et al. 1998 (Japanese EEG study, alpha-wave elevation at 50-200mg oral doses), Haskell et al. 2008 (Biological Psychology PMID: 18006208), which showed that 100mg L-theanine + 50mg caffeine produces faster attention-task reaction times and subjectively better mood than either compound alone, and Kimura et al. 2007 (Biological Psychology PMID: 16930802), which demonstrated that 200mg L-theanine reduces heart rate and salivary immunoglobulin A responses to an acute stress task — the cleanest human physiology demonstration of its anxiolytic effect. Supporting RCTs include Hidese et al. 2019 (Nutrients, 4-week 200mg/day for stress and sleep in healthy adults) and Lyon et al. 2011 (Alternative Medicine Review, 200mg BID improving sleep quality in boys with ADHD).
Pharmacologically, L-theanine crosses the blood-brain barrier via the large neutral amino acid transporter (LAT1), reaching brain tissue within 30-60 minutes of an oral dose. It has a plasma half-life of roughly 1-3 hours in humans, with central nervous system exposure outlasting plasma, and it acts on multiple neurotransmitter systems simultaneously (glutamate, GABA, dopamine, serotonin, catecholamines) — but at physiologic supplement doses its effects on any single system are modest. It is a weak, broadly-acting modulator rather than a strong selective agent. This is why it does NOT cause sedation, dependence, tolerance, or rebound the way GABAergic sedatives (phenibut, benzodiazepines, Z-drugs) do — you can take 200mg daily for years without tolerance development.
The largest user population is the caffeine-stack crowd — knowledge workers, students, coders, writers — taking 100-200mg caffeine daily for alertness and wanting to take the edge off the jitter without losing the focus boost. The canonical stack is 200mg caffeine + 200mg L-theanine taken together once in the morning. A second population uses it for acute stress (200mg, 30-60 minutes before a stressful event). A third cohort uses 400-600mg for schizophrenia-adjunctive anxiety based on the Ritsner 2011 data (PMID: 21208586). A fourth uses 200-400mg at bedtime for sleep quality, though the adult sleep evidence is weaker than the ADHD-boys data from Lyon 2011.
Where L-theanine does NOT work: it is not a sedative, not a cognitive enhancer in isolation (the attention benefit shows up only when paired with caffeine), not a panic-attack abortive, not an SSRI substitute for clinical depression or GAD, and not equivalent to meditation or therapy for chronic anxiety.
Safety profile stands out: FDA-GRAS since 2007 as Suntheanine®, rodent LD50 >5 g/kg (effectively unreachable at oral doses), decades of dietary human exposure through green tea, no dependence or withdrawal reported in any RCT. Side effects (mild headache, GI upset, dizziness at high doses) occur at placebo-comparable rates. The only meaningful practical cautions are possible additive hypotensive effect with blood-pressure medications and theoretical interaction with stimulant medications (though theanine + stimulant combinations are actually commonly used and well-tolerated).
L-theanine pairs well with nearly everything. The caffeine pair is canonical. Ashwagandha is increasingly common for daytime anxiolysis. Magnesium glycinate or L-threonate pairs for evening use. Rhodiola rosea + L-theanine + caffeine is a strong "calm focus + adaptogen" stack. Avoid stacking with strong sedatives (benzodiazepines, high-dose kava, phenibut in naive users) — not because of a specific interaction but because the subjective synergy blunts the productive-calm signature L-theanine is typically used for.
This is educational content and not medical advice; L-theanine is exceptionally safe for most healthy adults but blood-pressure medications, antipsychotics, and pregnancy/pediatric use warrant physician input before supplementation.
Chemical Information
IUPAC Name
Not yet available
CAS Number
Not yet available
Molecular Formula
Not yet available
Molecular Mass
174.20 g/mol
Dosing & Protocols
Unlock Dosing Protocols
Free account gets you:
- View beginner, intermediate & advanced protocols
- See weight-based dosing calculations
- Access cycle length & frequency data
2,800+ researchers already in
Research
Unlock Research Data
Free account gets you:
- Browse PubMed study summaries
- See clinical trial phases & results
- Access mechanism of action details
2,800+ researchers already in
Interactions
Contraindications
Absolute contraindications: none
L-theanine has one of the cleanest safety profiles in the nootropic category. No absolute contraindications have been established from controlled trials or post-marketing surveillance.
Relative contraindications / use with caution:
- Hypotension or orthostatic intolerance. Theanine modestly lowers BP (2-5 mmHg systolic at 200-400mg). In individuals with orthostatic hypotension, POTS, or borderline-low baseline BP, start at 100mg and assess.
- Antihypertensive medication. Additive BP reduction possible. Monitor BP on initiation; unlikely to require dose adjustment to BP medications but worth awareness.
- Pregnancy. Limited safety data beyond dietary green tea exposure. Low-to-moderate doses likely safe; high therapeutic doses should be discussed with clinician.
- Breastfeeding. Theanine crosses into breast milk (dietary exposure is unavoidable in tea-drinking cultures). Effect on infant unclear; clinician input recommended for supplemental doses.
- Severe hepatic impairment. Theanine is partially hepatic-metabolised; conservative dosing (100mg) is reasonable.
- Concurrent strong sedative use. Benzodiazepines, Z-drugs, high-dose kava — theoretical additive effect. Clinically usually trivial but worth awareness.
- Pediatric use outside research-supported indications. Lyon 2011 supports 200mg BID for 8-12yo boys with ADHD-sleep issues; other pediatric applications should involve clinician input.
Interactions (mostly benign):
- Caffeine. Favourable combination (standard of the nootropic field).
- Stimulant ADHD medications. Favourable combination; reduces jitter without blunting efficacy.
- SSRIs, SNRIs. No documented clinically significant interaction.
- Antipsychotics. Positive adjunctive data (Ritsner 2011); compatible.
- Anticoagulants. No interaction.
- Oral contraceptives. No interaction.
- Thyroid hormone. No interaction.
- Grapefruit juice. No interaction (not CYP3A4-metabolised).
Practical bottom line. For most healthy adults, L-theanine is safe to add without clinician consultation. The clearest caution is additive BP reduction with antihypertensives. Pregnancy, breastfeeding, and significant hepatic disease warrant discussion with a clinician, but the baseline safety profile is exceptional.
Research Disclaimer
This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.
$85.00
—
1
1
capsule
| Vendor | Product | Form | Qty | Price | $/mg | Coupon | |
|---|---|---|---|---|---|---|---|
| Composed — Calm Under Pressure | capsule | 0mg● In Stock | $85.00BEST | — |
Tracking since Apr 7, 2026 · 1 data point
Vendors Selling L-Theanine
How we score these vendors
Every supplier above is graded 0–100 on COA verification, payment transparency, shipping, reviews, and active listings. Methodology published, no pay-to-rank.
Related Compounds
View All9-MBC (9-Methyl-β-carboline)
NootropicsPreclinical9-Methyl-β-carboline (9-MBC) is a synthetic β-carboline alkaloid that has gained significant interest in the nootropic community for its reported ability to promote dopaminergic neuron growth, increase dopamine synthesis enzymes, and provide neuroprotective effects against neurotoxins.
Bromantane
NootropicsRussia ApprovedBromantane is an atypical psychostimulant and anxiolytic developed in the 1980s at the Zakusov Institute of Pharmacology of the Russian Academy of Medical Sciences, originally created as an adaptogen for Soviet military and elite athletic use and later approved in Russia for the treatment of neurasthenic and asthenic disorders under the trade name Ladasten.
Dihexa
NootropicsPreclinicalDihexa is a synthetic peptide analogue of the angiotensin IV metabolite LVV-hemorphin-7, developed at Washington State University.
Kavain
NootropicsPreclinicalActive compound from kava for relaxation and sleep support..
L-Tyrosine
NootropicsPreclinicalL-Tyrosine is a non-essential aromatic amino acid and the direct biosynthetic precursor to the catecholamine neurotransmitters dopamine, norepinephrine, and epinephrine.
Lion's Mane Mushroom
NootropicsPhase 2Lion's Mane (scientific name Hericium erinaceus; also known as yamabushitake in Japanese, houtou in Chinese, bearded tooth fungus, monkey head mushroom, and pom pom mushroom) is a white-to-cream coloured edible and medicinal mushroom in the tooth fungus family (Hericiaceae), characterised by its distinctive cascading spines that resemble a lion's mane or white cascading icicles.
Side-by-Side Comparisons
All ComparisonsView Full Dosage Guide →
Protocols, calculator & safety for L-Theanine
Related Articles
All PostsThe Complete Selank Nasal Spray Protocol — Mechanism, Dosing, and What 6 Weeks Taught Me
A complete Selank nasal spray protocol with dosing timeline, GABA-A mechanism breakdown, published research, and honest results from 6 weeks of daily use. Includes interactive half-life visualizer, dosing timeline, and comparison widget.
4/4/2026Adera State Review: Is the 5 States System Worth It? [Honest Assessment]
An honest, in-depth review of Adera State's 5 States nootropic system — product-by-product ingredient analysis, what we liked, what we didn't, and who should (and shouldn't) buy it.
4/3/2026We Compared 8 Focus Nootropics for 90 Days — Here's What Actually Works
We tested 8 popular focus nootropics over 90 days using objective metrics — reaction time, deep work hours, and daily focus ratings. Here are the honest results, including costs and side effects.
4/3/2026Research Score
1226 PubMed studies
Quality Indicators
Data Completeness
75%Research Credibility
Well-researched compound
Quick Facts
Half-Life
1-3 hours (plasma); central CNS effect 3-5 hours
Molecular Weight
174.20 g/mol
Administration
Oral
Trial Phase
FDA Approved
Research Disclaimer
This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use.
Frequently Asked Questions
What does L-theanine actually do — is the effect real?
Yes, the effect is real but subtle. L-theanine at 100-200mg produces measurable physiological changes (reduced heart rate response to stress, increased alpha-wave EEG activity, modest BP reduction) and subjective changes (reduced caffeine-associated jitter, smoother stress response, slightly calmer baseline mood). The magnitude of any individual effect is small — theanine is a weak, broad-acting modulator, not a strong selective drug. Users often describe the effect as 'removing something bad' (caffeine jitter, stress edge) rather than 'adding something good.' It is not a cognitive enhancer in isolation — its attention benefit shows up reliably only in combination with caffeine.
How much L-theanine should I take?
Start with 100mg paired with your usual caffeine. Most research-grade studies used 200mg as the single-dose standard. For acute stress, 200mg is well-established (Kimura 2007). For sleep, 200-400mg at bedtime. For antipsychotic-adjunctive use, 400mg/day (Ritsner 2011). The upper limit tested safely in trials is 900mg/day — there is no clinical reason to exceed 400mg per dose in most applications. Theanine has a flat dose-response curve above ~200mg, so doubling the dose rarely doubles the effect.
Does L-theanine work without caffeine?
Partially. Theanine alone produces measurable alpha-wave EEG changes, modest sympathetic dampening, and mild anxiolysis — these effects are real but subtle. The distinctive 'calm focus' cognitive enhancement most users associate with theanine shows up robustly only when paired with caffeine (Haskell 2008). If you don't drink caffeine, theanine still has utility as a gentle anxiolytic and sleep-quality supplement, but expect the effects to be smaller than the hype suggests.
When should I take L-theanine?
Depends on goal. For caffeine-paired focus: take with or 30 minutes before your morning caffeine. For acute stress: 30-60 minutes before the stressful event. For sleep: 30-60 minutes before intended sleep time. For daily anxiolytic: typically morning dose, with an optional second dose 4-6 hours later. The half-life is 1-3 hours, so multi-dose days are fine and don't produce accumulation.
Is L-theanine safe long-term?
Extraordinarily safe by nootropic standards. No dependence, no withdrawal, no tolerance development even after years of daily use. Decades of dietary green tea exposure provide a large real-world safety signal, and RCTs up to 16+ weeks at 400mg/day have shown no concerning adverse events. The main long-term consideration is that theanine alone is unlikely to fix clinically significant anxiety or mood disorders — don't use it as a substitute for proper treatment of those conditions.
Can I take L-theanine with antidepressants?
Yes, no documented clinically significant interaction with SSRIs, SNRIs, or tricyclics. Many users combine daily L-theanine with SSRI treatment for mild residual anxiety or sleep issues without problems. Not a substitute for the antidepressant; a reasonable low-risk adjunct.
What's the best form — Suntheanine, generic L-theanine, or green tea?
Suntheanine® is the most-studied form; generic L-theanine from reputable brands (NOW, Jarrow, Thorne, Pure Encapsulations, Doctor's Best, Bulk Supplements) is typically >98% pure and clinically equivalent. Avoid proprietary blends with unspecified theanine content. Green tea provides 8-25mg theanine per cup — useful for dietary exposure but impractical for clinical-effect dosing.
Can L-theanine help me sleep?
Modestly. 200-400mg at bedtime may improve subjective sleep quality and next-morning refreshment; it does not reliably shorten sleep-onset latency or act as a hypnotic. Best used as part of a sleep stack (magnesium glycinate, glycine, sleep hygiene) rather than a standalone sleep aid. For clinical insomnia, CBT-I, prescription sleep aids under clinician supervision, and evaluation for sleep disorders are better options.
Does L-theanine interact with blood pressure medications?
Possibly additive. Theanine produces 2-5 mmHg systolic BP reduction at 200-400mg doses. Combined with antihypertensives this is usually trivial but could produce occasional orthostatic symptoms on initiation. Monitor BP the first 1-2 weeks of daily use if you're on BP-lowering medication. Dose adjustment rarely required.
Can I take L-theanine during pregnancy or breastfeeding?
Limited safety data beyond dietary green tea exposure. Low-to-moderate doses (100-200mg) are likely safe given widespread dietary theanine exposure, but higher therapeutic doses during pregnancy or breastfeeding should be discussed with your clinician. If you are using theanine specifically for pregnancy-related anxiety or sleep issues, CBT, prenatal-safe SSRIs (where indicated), and non-pharmacological interventions are better-studied first-line options.
Research Tools
Related Compounds
View All9-MBC (9-Methyl-β-carboline)
NootropicsPreclinical9-Methyl-β-carboline (9-MBC) is a synthetic β-carboline alkaloid that has gained significant interest in the nootropic community for its reported ability to promote dopaminergic neuron growth, increase dopamine synthesis enzymes, and provide neuroprotective effects against neurotoxins.
Bromantane
NootropicsRussia ApprovedBromantane is an atypical psychostimulant and anxiolytic developed in the 1980s at the Zakusov Institute of Pharmacology of the Russian Academy of Medical Sciences, originally created as an adaptogen for Soviet military and elite athletic use and later approved in Russia for the treatment of neurasthenic and asthenic disorders under the trade name Ladasten.
Dihexa
NootropicsPreclinicalDihexa is a synthetic peptide analogue of the angiotensin IV metabolite LVV-hemorphin-7, developed at Washington State University.
Kavain
NootropicsPreclinicalActive compound from kava for relaxation and sleep support..
L-Tyrosine
NootropicsPreclinicalL-Tyrosine is a non-essential aromatic amino acid and the direct biosynthetic precursor to the catecholamine neurotransmitters dopamine, norepinephrine, and epinephrine.
Lion's Mane Mushroom
NootropicsPhase 2Lion's Mane (scientific name Hericium erinaceus; also known as yamabushitake in Japanese, houtou in Chinese, bearded tooth fungus, monkey head mushroom, and pom pom mushroom) is a white-to-cream coloured edible and medicinal mushroom in the tooth fungus family (Hericiaceae), characterised by its distinctive cascading spines that resemble a lion's mane or white cascading icicles.
Side-by-Side Comparisons
All ComparisonsCompare L-Theanine head-to-head: mechanism, half-life, dosing, safety, and live pricing.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.